Evaluation of Recurrence Factors and Gorei-san Administration for Chronic Subdural Hematoma after Percutaneous Subdural Tapping
Hiroshima Journal of Medical Sciences 62 巻 4 号
77-82 頁
2013-12 発行
アクセス数 : 1183 件
ダウンロード数 : 211 件
今月のアクセス数 : 7 件
今月のダウンロード数 : 1 件
この文献の参照には次のURLをご利用ください : https://ir.lib.hiroshima-u.ac.jp/00035415
ファイル情報(添付) |
HiroshimaJMedSci_62_77.pdf
202 KB
種類 :
全文
|
タイトル ( eng ) |
Evaluation of Recurrence Factors and Gorei-san Administration for Chronic Subdural Hematoma after Percutaneous Subdural Tapping
|
作成者 |
Okamura Akitake
Kawamoto Yukihiko
Sakoda Eiichirou
Murakami Taro
Hara Takeshi
|
収録物名 |
Hiroshima Journal of Medical Sciences
|
巻 | 62 |
号 | 4 |
開始ページ | 77 |
終了ページ | 82 |
収録物識別子 |
[PISSN] 0018-2052
[EISSN] 2433-7668
[NCID] AA00664312
|
抄録 |
Recent reports have shown that administration of Gorei-san (Tsumura, Tokyo, Japan) can prevent recurrence of chronic subdural hematoma (CSDH). However, no report has shown its potential, including its correlation with other recurrent clinical factors. We retrospectively evaluated the recurrent factors and the effects of Gorei-san on CSDH using percutaneous subdural tapping. Between April 2009 and February 2012, we performed percutaneous subdural tapping on 160 patients with intact CSDH. Of this population, 125 patients with unilateral hematoma and measurable initial hematoma pressure were included in this study. From April 2010, Gorei-san was routinely administered to patients. Patient characteristics such as age, sex, neurological grading, alcohol, diabetes mellitus, antiplatelet agent, anticoagulant agent, trauma, midline shift on CT images, hematoma volume on CT images, initial hematoma pressure, volume of the removed hematoma, and administration of Gorei-san were analyzed. Recurrence was recognized in 35/125 (28.0%) patients. Multivariate analysis revealed that a greater midline shift on CT images (p = 0.033) and initial hematoma pressure (p = 0.031) predicted recurrence. Goreisan was administered to 94/125 (75.2%) patients, but they showed no changes in recurrence (27.7% vs. 29.0%; p = 1.0). Among 13 patients for whom Gorei-san administration was started before surgery, CSDH recurrence was reported in only 1 (7.7%). However, the group showed a significantly lower number of recurrent factors. Patients with a greater midline shift in their CT images or higher initial hematoma pressure need close postsurgical observation. The potential of Gorei-san for preventing recurrence of CSDH needs further examination.
|
著者キーワード |
Chronic subdural hematoma
Recurrence
Gorei-san
Percutaneous subdural tapping
|
NDC分類 |
医学 [ 490 ]
|
言語 |
英語
|
資源タイプ | 紀要論文 |
出版者 |
Hiroshima University Medical Press
|
発行日 | 2013-12 |
権利情報 |
(c) Hiroshima University Medical Press.
|
出版タイプ | Version of Record(出版社版。早期公開を含む) |
アクセス権 | オープンアクセス |
収録物識別子 |
[ISSN] 0018-2052
[NCID] AA00664312
|